Development of a novel therapy for mitigation of the irradiation-inducedgastrointestinal syndrome
Ended Project Grant Awarded Last action
- Award ID
- R44AI138865
- Recipient
-
Bioincept LLC UEI FHUHJETDV881
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $207,237
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- New York, NY 10016, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $207,237 |
Quick answers
Who received award R44AI138865?
R44AI138865 was awarded to Bioincept LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2019.
How much is award R44AI138865 worth?
$207,237 has been obligated on R44AI138865.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award